Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03345134
Title Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Shaheen Alanee
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Shaheen Alanee, MD, MPH, MBA Detroit Michigan 48202 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field